💳 No credit card. No commitment. ⭐️️⭐️️⭐️️⭐️️⭐️️ 5,000+ G2 reviews
Company logo

Akron Molecules AG

Research

Akron Molecules AG information

Akron Molecules is a clinical-stage biotech company dedicated to the discovery and development of novel therapeutics for the treatment of human diseases with unmet medical need, including pain and metabolic disease.Akron Molecules has developed a "drug repurposing" strategy to identify new uses for existing compounds, based on world-class research. By focusing on the repositioning of compounds wit...
Akron Molecules is a clinical-stage biotech company dedicated to the discovery and development of novel therapeutics for the treatment of human diseases with unmet medical need, including pain and metabolic disease.Akron Molecules has developed a "drug repurposing" strategy to identify new uses for existing compounds, based on world-class research. By focusing on the repositioning of compounds with known pharmacological profiles to treat new indications, Akron Molecules aims to significantly reduce the time, cost and risk associated with drug development.

Highlights

0

Employee contacts

0

Employee email addresses

Unlock for free

Employee phone numbers

0

Technologies

0

News and Milestones

0

Job Postings

Financials

Industries

Research

Keywords

Drug development & drug repurposing
Biotechnology research

Akron Molecules AG Competitors

Akron Molecules AG Frequently Asked Questions

Where is Akron Molecules AG's headquarters?

Akron Molecules AG's headquarters is located in Vienna, Vienna.

How many employees does Akron Molecules AG have?

There are 1 employees at Akron Molecules AG.

How many funding rounds does Akron Molecules AG have?

Akron Molecules AG has been through 0 rounds of funding.

Employees


Looking for a particular Akron Molecules AG Employee?

Prospect on LinkedIn

Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Represents linkedin prospector

Evolve your team’s engagement & intelligence today.